[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Lyabin, D.N., Eliseeva, I.A. and Ovchinnikov, L.P. (2014) YB-1 Protein: Functions and Regulation. Wiley Interdisciplinary Reviews: RNA, 5, 95-110.
https://doi.org/10.1002/wrna.1200
|
[3]
|
Zasedateleva, O.A., Krylov, A.S., Prokopenko, D.V., Skabkin, M.A., Ovchinnikov, L.P., Kolchinsky, A., et al. (2002) Specificity of Mammalian Y-Box Binding Protein p50 in Interaction with ss and ds DNA Analyzed with Generic Oligonucleotide Microchip. Journal of Molecular Biology, 324, 73-87.
https://doi.org/10.1016/S0022-2836(02)00937-3
|
[4]
|
Weydert, C., van Heertum, B., Dirix, L., De Houwer, S., De Wit, F., Mast, J., et al. (2018) Y-Box-Binding Protein 1 Supports the Early and Late Steps of HIV Replication. PLoS ONE, 13, e0200080. https://doi.org/10.1371/journal.pone.0200080
|
[5]
|
Alemasova, E.E., Moor, N.A., Naumenko, K.N., Kutuzov, M.M., Sukhanova, M.V., Pestryakov, P.E., et al. (2016) Y-Box-Binding Protein 1 as a Non-Canonical Factor of Base Excision Repair. Biochimica et Biophysica Acta, 1864, 1631-1640.
https://doi.org/10.1016/j.bbapap.2016.08.012
|
[6]
|
Higashi, K., Inagaki, Y., Suzuki, N., Mitsui, S., Mauviel, A., Kaneko, H., et al. (2003) Y-Box-Binding Protein YB-1 Mediates Transcriptional Repression of Human Alpha 2(I) Collagen Gene Expression by Interferon-Gamma. The Journal of Biological Chemistry, 278, 5156-5162. https://doi.org/10.1074/jbc.M208724200
|
[7]
|
Prabhu, L., Hartley, A.V., Martin, M., Warsame, F., Sun, E. and Lu, T. (2015) Role of Post-Translational Modification of the Y Box Binding Protein 1 in Human Cancers. Genes and Diseases, 2, 240-246. https://doi.org/10.1016/j.gendis.2015.05.001
|
[8]
|
Lyabin, D.N., Doronin, A.N., Eliseeva, I.A., Guens, G.P., Kulakovskiy, I.V. and Ovchinnikov, L.P. (2014) Alternative Forms of Y-Box Binding Protein 1 and YB-1 mRNA. PLoS ONE, 9, e104513. https://doi.org/10.1371/journal.pone.0104513
|
[9]
|
Nishio, S., Ushijima, K., Yamaguchi, T., Sasajima, Y., Tsuda, H., Kasamatsu, T., et al. (2014) Nuclear Y-Box-Binding Protein-1 Is a Poor Prognostic Marker and Related to Epidermal Growth Factor Receptor in Uterine Cervical Cancer. Gynecologic Oncology, 132, 703-708. https://doi.org/10.1016/j.ygyno.2014.01.045
|
[10]
|
Panupinthu, N., Yu, S., Zhang, D., Zhang, F., Gagea, M., Lu, Y., et al. (2014) Self-Reinforcing Loop of Amphiregulin and Y-Box Binding Protein-1 Contributes to Poor Outcomes in Ovarian Cancer. Oncogene, 33, 2846-2856.
https://doi.org/10.1038/onc.2013.259
|
[11]
|
Guo, T., Yu, Y., Yip, G.W., Baeg, G.H., Thike, A.A., Lim, T.K., et al. (2015) Y-Box Binding Protein 1 Is Correlated with Lymph Node Metastasis in Intestinal-Type Gastric Cancer. Histopathology, 66, 491-499. https://doi.org/10.1111/his.12570
|
[12]
|
Yan, X., Yan, L., Zhou, J., Liu, S., Shan, Z., Jiang, C., et al. (2014) High Expression of Y-Box-Binding Protein 1 Is Associated with Local Recurrence and Predicts Poor Outcome in Patients with Colorectal Cancer. International Journal of Clinical and Experimental Pathology, 7, 8715-8723.
|
[13]
|
Eliseeva, I.A., Kim, E.R., Guryanov, S.G., Ovchinnikov, L.P. and Lyabin, D.N. (2011) Y-Box-Binding Protein 1 (YB-1) and Its Functions. Biochemistry, 76, 1402-1433.
https://doi.org/10.1134/S0006297911130049
|
[14]
|
Nagasu, S., Sudo, T., Kinugasa, T., Yomoda, T., Fujiyoshi, K., Shigaki, T., et al. (2019) Y-Box-Binding Protein 1 Inhibits Apoptosis and Upregulates EGFR in Colon Cancer. Oncology Reports, 41, 2889-2896. https://doi.org/10.3892/or.2019.7038
|
[15]
|
Yang, J.Y., Ha, S.A., Yang, Y.S. and Kim, J.W. (2010) p-Glycoprotein ABCB5 and YB-1 Expression Plays a Role in Increased Heterogeneity of Breast Cancer Cells: Correlations with Cell Fusion and Doxorubicin Resistance. BMC Cancer, 10, 388.
https://doi.org/10.1186/1471-2407-10-388
|
[16]
|
Evdokimova, V., Tognon, C., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., et al. (2009) Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition. Cancer Cell, 15, 402-415. https://doi.org/10.1016/j.ccr.2009.03.017
|
[17]
|
Landskron, G., De La Fuente, M., Thuwajit, P., Thuwajit, C. and Hermoso, M.A. (2014) Chronic Inflammation and Cytokines in the Tumor Microenvironment. Journal of Immunology Research, 2014, Article ID: 149185.
https://doi.org/10.1155/2014/149185
|
[18]
|
Gyamfi, J., Eom, M., Koo, J.S. and Choi, J. (2017) Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction. Translational Oncology, 11, 275-285. https://doi.org/10.1016/j.tranon.2017.12.009
|
[19]
|
Zhang, S., Yang, X., Wang, L. and Zhang, C. (2018) Interplay between Inflammatory Tumor Microenvironment and Cancer Stem Cells. Oncology Letters, 16, 679-686.
https://doi.org/10.3892/ol.2018.8716
|
[20]
|
Sehgal, P.B. (2010) Interleukin-6 Induces Increased Motility, Cell-Cell and Cell-Substrate Dyshesion and Epithelial-to-Mesenchymal Transformation in Breast Cancer Cells. Oncogene, 29, 2599-2600. https://doi.org/10.1038/onc.2010.4
|
[21]
|
Sullivan, N.J., Sasser, A.K., Axel, A.E., Vesuna, F., Raman, V., Ramirez, N., et al. (2009) Interleukin-6 Induces an Epithelial-Mesenchymal Transition Phenotype in Human Breast Cancer Cells. Oncogene, 28, 2940-2947.
https://doi.org/10.1038/onc.2009.180
|
[22]
|
Wang, X., Guo, X.B., Shen, X.C., Zhou, H., Wan, D.W., Xue, X.F., et al. (2015) Prognostic Role of YB-1 Expression in Breast Cancer: A Meta-Analysis. International Journal of Clinical and Experimental Medicine, 8, 1780.
|
[23]
|
Frye, B.C., Halfter, S., Djudjaj, S., Muehlenberg, P., Weber, S. and Raffetseder, U. (2009) Y-Box Protein-1 Is Actively Secreted through a Non-Classical Pathway and Acts as an Extracellular Mitogen. EMBO Reports, 10, 783-789.
https://doi.org/10.1038/embor.2009.81
|
[24]
|
Tacke, F., Galm, O., Kanig, N., Yagmur, E., Brandt, S., Lindquist, J.A., et al. (2014) High Prevalence of Y-Box Protein-1/p18 Fragment in Plasma of Patients with Malignancies of Different Origin. BMC Cancer, 14, 33.
https://doi.org/10.1186/1471-2407-14-33
|
[25]
|
Ma, Y., Ren, Y., Dai, Z.J., Wu, C.J., Ji, Y.H. and Xu, J. (2017) IL-6, IL-8 and TNF-Alpha Levels Correlate with Disease Stage in Breast Cancer Patients. Advances in Clinical and Experimental Medicine, 26, 421-426.
https://doi.org/10.17219/acem/62120
|
[26]
|
Milovanovic, J., Todorovic-Rakovic, N. and Radulovic, M. (2019) Interleukin-6 and Interleukin-8 Serum Levels in Prognosis of Hormone-Dependent Breast Cancer. Cytokine, 118, 93-98. https://doi.org/10.1016/j.cyto.2018.02.019
|
[27]
|
Won, H.S., Kim, Y.A., Lee, J.S., Jeon, E.K., An, H.J., Sun, D.S., et al. (2013) Soluble Interleukin-6 Receptor Is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer. Cancer Investigation, 8, 516-521.
https://doi.org/10.3109/07357907.2013.826239
|
[28]
|
Studebaker, A.W., Storci, G., Werbeck, J.L., Sansone, P., Sasser, A.K., Tavolari, S., et al. (2008) Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6-Dependent Manner. Cancer Research, 68, 9087-9095.
https://doi.org/10.1158/0008-5472.CAN-08-0400
|
[29]
|
Sasser, A.K., Sullivan, N.J., Studebaker, A.W., Hendey, L.F., Axel, A.E. and Hall, B.M. (2007) Interleukin-6 Is a Potent Growth Factor for ER-Alpha-Positive Human Breast Cancer. The FASEB Journal, 21, 3763-3770.
https://doi.org/10.1096/fj.07-8832com
|
[30]
|
Astanehe, A., Finkbeiner, M.R., Krzywinski, M., Fotovati, A., Dhillon, J., Berquin, I.M., et al. (2012) MKNK1 Is YB-1 Target Gene Responsible for Imparting Trastuzumab Resistance and Can Be Blocked by RSK Inhibition. Oncogene, 31, 4434-4446. https://doi.org/10.1038/onc.2011.617
|
[31]
|
Castellana, B., Aasen, T., Moreno-Bueno, G., Dunn, S.E. and Ramón y Cajal, S. (2015) Interplay between YB-1 and IL-6 Promotes the Metastatic Phenotype in Breast Cancer Cells. Oncotarget, 6, 38239-38256.
https://doi.org/10.18632/oncotarget.5664
|
[32]
|
Grivennikov, S. and Karin, M. (2008) Autocrine IL-6 Signaling: A Key Event in Tumorigenesis? Cancer Cell, 13, 7-9. https://doi.org/10.1016/j.ccr.2007.12.020
|
[33]
|
Song, Y.H., Shiota, M., Yokomizo, A., Uchiumi, T., Kiyoshima, K., Kuroiwa, K., et al. (2014) Twist1 and Y-Box-Binding Protein-1 Are Potential Prognostic Factors in Bladder Cancer. Urologic Oncology, 32, 31.e1-7.
https://doi.org/10.1016/j.urolonc.2012.11.003
|
[34]
|
Zhu, X., Tao, L., Yao, J., Sun, P., Pei, L., Li, J., et al. (2014) Identification of Collaboration Patterns of Dysfunctional Pathways in Breast Cancer. International Journal of Clinical and Experimental Pathology, 7, 3853-3864.
|
[35]
|
Ferreira, A.R., Bettencourt, M., Alho, I., Costa, A.L., Sousa, A.R. and Mansinho, A. (2017) Serum YB-1 (Y-Box Binding Protein 1) as a Biomarker of Bone Disease Progression in Patients with Breast Cancer and Bone Metastases. Journal of Bone Oncology, 6, 16-21. https://doi.org/10.1016/j.jbo.2017.01.002
|
[36]
|
Huang, X., Ushijima, K., Komai, K., Takemoto, Y., Motoshima, S., Kamura, T. and Kohno, K. (2004) Co-Expression of Y Box-Binding Protein-1 and P-Glycoprotein as a Prognostic Marker for Survival in Epithelial Ovarian Cancer. Gynecologic Oncology, 93, 287-291. https://doi.org/10.1016/j.ygyno.2004.01.040
|
[37]
|
Abd El-Maqsoud, N.M., Osman, N.A., Abd El-Hamid, A.M., Fath El-Bab, T.K. and Galal, E.M. (2016) Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating with Poor Prognosis in Prostate Cancer. Clinical Genitourinary Cancer, 14, e143-e152. https://doi.org/10.1016/j.clgc.2015.12.015
|
[38]
|
Kariminia, A., Ivison, S.M., Leung, V.M., Sung, S., Couto, N., Rozmus, J., et al. (2017) Y-Box-Binding Protein 1 Contributes to IL-7-Mediated Survival Signaling in B-Cell Precursor Acute Lymphoblastic Leukemia. Oncology Letters, 13, 497-505.
https://doi.org/10.3892/ol.2016.5437
|
[39]
|
Chatterjee, M., Rancso, C., Stühmer, T., Eckstein, N., Andrulis, M., Gerecke, C., et al. (2008) The Y-Box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma. Blood, 111, 3714-3722. https://doi.org/10.1182/blood-2007-05-089151
|
[40]
|
Rohr, I., Braicu, E.I., En-Nia, A., Heinrich, M., Richter, R., Chekerov, R., et al. (2016) Y-Box Protein-1/p18 as Novel Serum Marker for Ovarian Cancer Diagnosis: A Study by the Tumor Bank Ovarian Cancer (TOC). Cytokine, 85, 157-164.
https://doi.org/10.1016/j.cyto.2016.06.021
|